# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Congenital hemolytic anemia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 149 results.
Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Status: Recruiting
Last Changed: Mar 05, 2019
First Received: May 29, 2003
Disease(s): Congenital Hemolytic Anemia, Sickle Cell Disease
Intervention(s): Peripheral blood hematopoietic progenitor cell (PBPC) transplant, Alemtuzumab, Peripheral blood hematopoieticprogenitor cell Apherisis, Sirolimus
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Pyruvate Kinase Deficiency Global Longitudinal Registry
Status: Recruiting
Last Changed: Jul 02, 2019
First Received: Mar 29, 2018
Disease(s): Pyruvate Kinase Deficiency
Locations: Phoenix Childrens Hospital, Phoenix, Arizona, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Children's Hospital of Orange County, Orange, California, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
... and 43 other locations.
Registry of Congenital Dyserythropoietic Anemia
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Jun 12, 2019
Disease(s): Congenital Dyserythropoietic Anemia
Intervention(s): Collection of data and genetic analysis
Locations: Hôpital Saint-Vincent de Paul, Lille, Hauts-de-France, France
The Congenital Dyserythropoietic Anemia Registry (CDAR)
Status: Recruiting
Last Changed: Dec 20, 2018
First Received: Nov 16, 2016
Disease(s): Congenital Dyserythropoietic Anemia (CDA)
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)
Status: Recruiting
Last Changed: Jul 09, 2019
First Received: Jun 18, 2018
Disease(s): Pyruvate Kinase Deficiency, Anemia, Hemolytic
Intervention(s): AG-348
Locations: UCSF Benioff Children's Hospital, Oakland, California, United States
Stanford University, Palo Alto, California, United States
Emory University, Atlanta, Georgia, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Seattle Cancer Care Alliance, Seattle, Washington, United States
... and 19 other locations.
A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)
Status: Recruiting
Last Changed: Jul 09, 2019
First Received: Jun 07, 2018
Disease(s): Pyruvate Kinase Deficiency, Anemia, Hemolytic
Intervention(s): AG-348, Placebo
Locations: Phoenix Children's Hospital, Phoenix, Arizona, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
UCSF Benioff Children's Hospital, Oakland, California, United States
Stanford University, Palo Alto, California, United States
Emory University, Atlanta, Georgia, United States
... and 47 other locations.
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Status: Recruiting
Last Changed: Sep 17, 2018
First Received: Dec 09, 2010
Disease(s): Thrombotic Thrombocytopenic Purpura, Congenital Thrombotic Thrombocytopenic Purpura, Familial Thrombotic Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura, Congenital, Upshaw-Schulman Syndrome
Intervention(s): Observation
Locations: University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901, Oklahoma City, Oklahoma, United States
Medical University of Vienna, Department of Medicine 1, Div. Hematology and Hemostasis Waehringer Guertel 18-20, Vienna, Austria
Institute of Hematology and Blood Transfusion, Coagulation Laboratory, U nemocnice 1, Prague 2, Czechia
University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistr 52, Hamburg, Germany
Nara Medical University, Department of Blood Transfusion Medicine, Shijyo-cho 840, Kashihara city, Nara, Japan
... and 3 other locations.
Pyruvate Kinase Deficiency Epidemiological Study (PIECE)
Status: Not yet recruiting
Last Changed: May 15, 2019
First Received: Mar 07, 2019
Disease(s): Pyruvate Kinase Deficiency
Intervention(s): Genetic test
SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain
Status: Recruiting
Last Changed: Apr 02, 2018
First Received: Dec 30, 2016
Disease(s): Sickle Cell Disease, Anemia, Anemia, Hemolytic, Anemia, Sickle Cell, Hematologic Diseases
Intervention(s): PROMIS for Pain Management App
Locations: Children's National Medical Center, Washington, District of Columbia, United States
Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007
Status: Recruiting
Last Changed: Jun 28, 2019
First Received: Feb 26, 2019
Disease(s): Pyruvate Kinase Deficiency
Intervention(s): AG-348
Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
UCSF Benioff Children's Hospital, Oakland, Oakland, California, United States
Stanford University, Palo Alto, California, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Indiana Hemophilia & Thrombosis Center Inc., Indianapolis, Indiana, United States
... and 46 other locations.